# Lisdexamfetamine's Effect In ADHD in the Brain and Cognition

> **NCT02170298** · PHASE4 · TERMINATED · sponsor: **University of California, Davis** · enrollment: 6 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Lisdexamfetamine

## Key facts

- **NCT ID:** NCT02170298
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2019-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02170298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02170298, "Lisdexamfetamine's Effect In ADHD in the Brain and Cognition". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02170298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*